| GTO ID | GTC0770 |
| Trial ID | ChiCTR1800018902 |
| Disease | B-Cell Malignancy |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Targeting CD19 chimeric antigen receptor gene modified autologous T cells (CD19 CAR-T) for the treatment of CD19 positive recurrent and refractory B cell malignancies |
| Year | 2018 |
| Country | China |
| Company sponsor | Department of Hematology, Wuxi people's Hospital |
| Cohort 1 | |||||||
|
|||||||